[Delirium in the "young" covid-19 patient (<65 years): preliminary clinical indications]. / Il delirium nel paziente covid-19 "giovane" (<65 anni): indicazioni cliniche preliminari.
Riv Psichiatr
; 56(2): 85-92, 2021.
Article
in Italian
| MEDLINE | ID: covidwho-1201375
ABSTRACT
Delirium is a phenomenon classified within neuro-cognitive disorders in the DSM-5. It has several etiologies and it is often lethal. This contribute aims at analyzing clinical characteristics and diagnostic possibilities of delirium in patients affected by covid-19. Furthermore, some preliminary recommendations on the use of psychopharmacological treatment of delirium and their interactions with main drugs used to treat covid-19 are given, with a special attention to comorbidities like in immunocompromised patients, in those affected by diabetes and cancer, in pregnant women or in addicted clients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Delirium
/
COVID-19
Type of study:
Diagnostic study
/
Etiology study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Middle aged
Language:
Italian
Journal:
Riv Psichiatr
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS